SAN JOSE, Calif., Feb. 26, 2025 /PRNewswire/ -- Visby Medical ™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the U.S. Food and Drug Administration (FDA) for ...

Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 developmentGLEN ALLEN, Va., ...

First mass spectrometry-based test system for total 25-Hydroxyvitamin D to receive CLIA 'Moderate Complexity' designation in the U.S. Expands access to advanced testing with a fully automated, ...

In one of the first demonstrations of the impact of last year’s Loper Supreme Court decision on challenges to agency ...

An ethyl alcohol (ETOH) assay from Carolina Liquid Chemistries Corp. (CLC) has been categorized as moderately complex under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for use on the ...

This agreement aligns with our commitment to provide the most innovative point of care diagnostic solutions to our clients.

Thermo Fisher Scientific has launched the new Molecular Microscope Diagnostic System for Lung (MMDx Lung), a new test to assist in evaluating lung transplant biopsies, which could lead to the ...

The BrightKaire test converts stem cells to neurons and exposes those neurons to different antidepressants to determine how ...

Quest Diagnostics' Haystack Oncology joins Rutgers Cancer Institute to study how its ctDNA MRD test can guide therapy for stage II/III lung cancer.

Adial Pharmaceuticals (ADIL) announced the successful completion of the analytical validation of a cheek swab collection method for testing ...